Everhart Financial Group Inc. Acquires 150 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Everhart Financial Group Inc. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,196 shares of the medical equipment provider’s stock after acquiring an additional 150 shares during the quarter. Everhart Financial Group Inc.’s holdings in Intuitive Surgical were worth $1,668,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the third quarter worth $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG stock opened at $595.55 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business’s 50-day moving average is $559.48 and its two-hundred day moving average is $519.06. The company has a market cap of $212.12 billion, a price-to-earnings ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.